Page last updated: 2024-08-23

radium and prednisone

radium has been researched along with prednisone in 24 studies

Research

Studies (24)

TimeframeStudies, this research(%)All Research%
pre-19905 (20.83)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's12 (50.00)24.3611
2020's7 (29.17)2.80

Authors

AuthorsStudies
Corby, DG; Louro, JM; Oquendo-Cabrera, A1
Waldeyer, L1
TRONCONI, G1
van BOUWDYK BASTIAANSE, M1
FAYOS, JV1
Kang, I; Kang, Y; Kim, JW; Petrylak, DP; Shin, MS1
Harrelson, SS; Mariados, NF; Mehlhaff, BA; Nordquist, LT; Shore, ND; Steere, KJ; Tutrone, RF1
Cicero, G; Costa, RP; De Luca, R; Murabito, A; Tripoli, V1
Gourd, E1
Berruti, A; Dalla Volta, A; Formenti, AM1
Boegemann, M; Heidenreich, A; Higano, C; Kakehi, Y; Karyakin, O; Kimura, G; Krissel, H; Matsubara, N; Matveev, V; Miller, K; Nahas, WC; Ng, QS; Nolè, F; Parker, C; Piulats, JM; Rosenbaum, E; Saad, F; Shen, J; Smith, M; Teufel, M; Tombal, B; Wagner, V; Zhang, A; Zucca, LE1
Spratt, DE1
Cursano, MC; De Giorgi, U; Iuliani, M; Paganelli, G; Santini, D1
Hindié, E; Morgat, C1
van der Poel, H1
Fujii, Y; Hinotsu, S; Izumi, K; Kimura, G; Mizokami, A1
Figg, WD; Knechel, MA; Schmidt, KT1
Hosono, M; Kakehi, Y; Kikukawa, H; Kimura, G; Kinuya, S; Krissel, H; Matsubara, N; Mizokami, A; Nagamori, S; Nakamura, M; Siegel, J; Uemura, H1
George, DJ; Higano, CS; Jiao, X; Kalinovsky, J; Miller, K; Saad, F; Sartor, O; Shore, N; Sternberg, CN; Tangirala, K; Tombal, B1
Abou Chakra, M; Dellis, A; Moussa, M; Papatsoris, A; Sryropoulou, D1
Albany, C; Dawson, NA; Higano, CS; Mehlhaff, BA; Nordquist, LT; Patel, KR; Petrylak, DP; Quinn, DI; Sartor, O; Siegel, J; Trandafir, L; Vaishampayan, UN; Wagner, VJ1
Agarwal, N; Bruno, A; George, D; Guo, H; Higano, CS; Jiao, X; Miller, K; Saad, F; Sandström, P; Sartor, O; Shore, N; Sternberg, CN; Tombal, B; Verholen, F1
Dai, JD; Shen, PF; Sun, GX; Wang, MH; Xu, NW; Zeng, H; Zeng, YH; Zhang, XM; Zhao, JG1

Reviews

3 review(s) available for radium and prednisone

ArticleYear
Interim Results From ERADICATE: An Open-Label Phase 2 Study of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Castration-Resistant Prostate Cancer Subjects With Symptomatic Bone Metastases.
    Clinical advances in hematology & oncology : H&O, 2016, Volume: 14, Issue:4 Suppl 5

    Topics: Abiraterone Acetate; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemoradiotherapy; Clinical Trials, Phase II as Topic; Humans; Male; Prednisone; Proportional Hazards Models; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radioisotopes; Radium; Treatment Outcome

2016
Pharmacotherapeutic strategies for castrate-resistant prostate cancer.
    Expert opinion on pharmacotherapy, 2020, Volume: 21, Issue:12

    Topics: Abiraterone Acetate; Androstenes; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Clinical Trials as Topic; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Humans; Immunotherapy; Male; Nitriles; Phenylthiohydantoin; Prednisone; Progression-Free Survival; Prostatic Neoplasms, Castration-Resistant; Radium; Taxoids; Tissue Extracts

2020
The safety of radium-223 combined with new-generation hormonal agents in bone metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis.
    Asian journal of andrology, 2023, Volume: 25, Issue:4

    Topics: Abiraterone Acetate; Antineoplastic Combined Chemotherapy Protocols; Fractures, Bone; Humans; Male; Network Meta-Analysis; Prednisone; Prostatic Neoplasms, Castration-Resistant; Radium

2023

Trials

4 trial(s) available for radium and prednisone

ArticleYear
eRADicAte: A Prospective Evaluation Combining Radium-223 Dichloride and Abiraterone Acetate Plus Prednisone in Patients With Castration-Resistant Prostate Cancer.
    Clinical genitourinary cancer, 2018, Volume: 16, Issue:2

    Topics: Abiraterone Acetate; Aged; Aged, 80 and over; Humans; Male; Middle Aged; Prednisone; Prospective Studies; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radioisotopes; Radium; Treatment Outcome

2018
Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial.
    The Lancet. Oncology, 2019, Volume: 20, Issue:3

    Topics: Abiraterone Acetate; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Double-Blind Method; Fractures, Bone; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Prednisolone; Prednisone; Progression-Free Survival; Prostatic Neoplasms, Castration-Resistant; Radium

2019
A randomized, double-blind, comparison of radium-223 and placebo, in combination with abiraterone acetate and prednisolone, in castration-resistant metastatic prostate cancer: subgroup analysis of Japanese patients in the ERA 223 study.
    International journal of clinical oncology, 2020, Volume: 25, Issue:4

    Topics: Abiraterone Acetate; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asian People; Bone Neoplasms; Disease-Free Survival; Double-Blind Method; Fractures, Bone; Humans; Male; Middle Aged; Placebos; Prednisolone; Prednisone; Prostatic Neoplasms, Castration-Resistant; Radium; Treatment Outcome

2020
A randomized phase IIa study of quantified bone scan response in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 dichloride alone or in combination with abiraterone acetate/prednisone or enzalutamide.
    ESMO open, 2021, Volume: 6, Issue:2

    Topics: Abiraterone Acetate; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Humans; Male; Nitriles; Phenylthiohydantoin; Prednisone; Prostatic Neoplasms, Castration-Resistant; Radium; Tomography, X-Ray Computed

2021

Other Studies

17 other study(ies) available for radium and prednisone

ArticleYear
Thrombocytopenia in a patient with a relatively small facial hemangioma. Successful management with irradiation after failure of prednisone therapy.
    Clinical pediatrics, 1969, Volume: 8, Issue:12

    Topics: Facial Neoplasms; Female; Hemangioma; Humans; Infant; Prednisone; Radium; Thrombocytopenia

1969
[The further course of Hand-Schueller-Christian disease of the cervix and vagina].
    Zentralblatt fur Gynakologie, 1966, Apr-16, Volume: 88, Issue:16

    Topics: Adult; Chlortetracycline; Female; Histiocytosis, Langerhans-Cell; Humans; Lung Neoplasms; Menstruation Disturbances; Prednisone; Radium; Sulfisomidine; Uterine Cervical Diseases; Vaginal Diseases; Vulvar Neoplasms

1966
[Prevention and therapy of vagino-proctitis caused by radium].
    Annali di ostetricia e ginecologia, 1960, Volume: 82

    Topics: Disease; Female; Humans; Prednisone; Proctitis; Radium; Rectal Diseases; Rectum; Uterine Cervical Neoplasms; Vaginitis

1960
[Operation of a large radium fistula].
    Zentralblatt fur Gynakologie, 1963, May-25, Volume: 85

    Topics: Female; Fistula; Humans; Prednisolone; Prednisone; Radiation Injuries; Radium; Vesicovaginal Fistula

1963
A COMPLICATION OF STEROID TREATMENT AFTER RADIOTHERAPY OF CARCINOMA OF THE UTERINE CERVIX; REPORT OF A CASE.
    Radiology, 1964, Volume: 82

    Topics: Carcinoma, Squamous Cell; Cobalt Isotopes; Female; Geriatrics; Humans; Hydrocortisone; Necrosis; Neoplasms; Peritonitis; Prednisone; Radiation Injuries; Radium; Toxicology; Uterine Cervical Neoplasms; Vagina

1964
Immune Analysis of Radium-223 in Patients With Metastatic Prostate Cancer.
    Clinical genitourinary cancer, 2018, Volume: 16, Issue:2

    Topics: Administration, Intravenous; Aged; Aged, 80 and over; Bone Neoplasms; CD8-Positive T-Lymphocytes; Humans; Interferon-gamma; Interleukin-13; Male; Middle Aged; Prednisone; Programmed Cell Death 1 Receptor; Prostatic Neoplasms, Castration-Resistant; Radium; Treatment Outcome; Tumor Necrosis Factor-alpha

2018
The Clinical Efficacy of Radium-223 for Bone Metastasis in Patients with Castration-Resistant Prostate Cancer: An Italian Clinical Experience.
    Oncology, 2018, Volume: 94, Issue:3

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Docetaxel; Humans; Italy; Male; Middle Aged; Prednisone; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radioisotopes; Radium; Retrospective Studies; Taxoids

2018
EMA guidance on radium-223 dichloride in prostate cancer.
    The Lancet. Oncology, 2018, Volume: 19, Issue:4

    Topics: Abiraterone Acetate; Antineoplastic Combined Chemotherapy Protocols; European Union; Fractures, Bone; Humans; Male; Prednisone; Prostatic Neoplasms; Radioisotopes; Radium; Survival Rate

2018
Higher Risk of Fragility Fractures in Prostate Cancer Patients Treated with Combined Radium-223 and Abiraterone: Prednisone May Be the Culprit.
    European urology, 2019, Volume: 75, Issue:6

    Topics: Abiraterone Acetate; Androstenes; Antineoplastic Combined Chemotherapy Protocols; Fractures, Bone; Humans; Male; Prednisone; Prostatic Neoplasms, Castration-Resistant; Radium; Treatment Outcome

2019
Combination therapies in prostate cancer: proceed with caution.
    The Lancet. Oncology, 2019, Volume: 20, Issue:3

    Topics: Abiraterone Acetate; Double-Blind Method; Humans; Male; Prednisolone; Prednisone; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radium

2019
Early use of abiraterone and radium-223 in metastatic prostate cancer.
    The Lancet. Oncology, 2019, Volume: 20, Issue:5

    Topics: Abiraterone Acetate; Androstenes; Double-Blind Method; Humans; Male; Prednisolone; Prednisone; Prostatic Neoplasms, Castration-Resistant; Radium

2019
Early use of abiraterone and radium-223 in metastatic prostate cancer.
    The Lancet. Oncology, 2019, Volume: 20, Issue:5

    Topics: Abiraterone Acetate; Androstenes; Double-Blind Method; Humans; Male; Prednisolone; Prednisone; Prostatic Neoplasms, Castration-Resistant; Radium

2019
Re: Addition of Radium-223 to Abiraterone Acetate and Prednisone or Prednisolone in Patients with Castration-resistant Prostate Cancer and Bone Metastases (ERA 223): A Randomised, Double-blind, Placebo-controlled, Phase 3 Trial.
    European urology, 2019, Volume: 76, Issue:5

    Topics: Abiraterone Acetate; Bone Neoplasms; Double-Blind Method; Humans; Male; Prednisolone; Prednisone; Prostatic Neoplasms, Castration-Resistant; Radium

2019
Considering bone health in the treatment of prostate cancer bone metastasis based on the results of the ERA-223 trial.
    International journal of clinical oncology, 2019, Volume: 24, Issue:12

    Topics: Abiraterone Acetate; Bone Density; Bone Neoplasms; Double-Blind Method; Humans; Male; Prednisolone; Prednisone; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radium

2019
Combination treatment in metastatic castration-resistant prostate cancer: can we safely boost efficacy by adding radium-223?
    Cancer biology & therapy, 2020, Volume: 21, Issue:1

    Topics: Abiraterone Acetate; Antineoplastic Combined Chemotherapy Protocols; Double-Blind Method; Humans; Male; Prednisolone; Prednisone; Prostatic Neoplasms, Castration-Resistant; Radium

2020
Concurrent or layered treatment with radium-223 and enzalutamide or abiraterone/prednisone: real-world clinical outcomes in patients with metastatic castration-resistant prostate cancer.
    Prostate cancer and prostatic diseases, 2020, Volume: 23, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Androstenes; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Density Conservation Agents; Bone Neoplasms; Chemoradiotherapy; Clinical Trials, Phase III as Topic; Denosumab; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Metastasis; Nitriles; Phenylthiohydantoin; Prednisone; Prostatic Neoplasms, Castration-Resistant; Radium; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Rate; Treatment Outcome; Zoledronic Acid

2020
Real-world outcomes of second novel hormonal therapy or radium-223 following first novel hormonal therapy for mCRPC.
    Future oncology (London, England), 2022, Volume: 18, Issue:1

    Topics: Abiraterone Acetate; Aged; Aged, 80 and over; Benzamides; Bone Neoplasms; Humans; Male; Middle Aged; Nitriles; Phenylthiohydantoin; Prednisone; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies

2022